Pharma 4.0: Pandemic pushed reluctant pharma companies to adopt advanced technologies
Pharma industry is ready to embrace technology platforms with a keen focus on automation in manufacturing and digital health investment.
Pharma industry is ready to embrace technology platforms with a keen focus on automation in manufacturing and digital health investment.
The new site will produce next-generation synthetic medicine active pharmaceutical ingredients
The center will offer training to super-specialist doctors and healthcare professionals in various fields
Company plans to create 100 manufacturing jobs and up to 1,000 construction jobs
Amgen has invested over $40 billion in manufacturing and research and development in US since 2017
Air Liquide will provide care for people living with respiratory diseases such as chronic obstructive pulmonary disease (COPD) and sleep apnea
Includes new $1.2 billion investment in manufacturing facilities, AI and advanced digital technologies, creating hundreds of highly skilled U.S. jobs
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
Subscribe To Our Newsletter & Stay Updated